Dustin Elizabeth, Suarez-Pozos Edna, Stotesberry Camryn, Qiu Shulan, Palavicini Juan Pablo, Han Xianlin, Dupree Jeffrey L
Research Service, Richmond Veterans Affairs Medical Center, Central Virginia Veterans Affairs Health Care System, Richmond, VA 23249, USA.
Department of Anatomy and Neurobiology, Virginia Commonwealth University, Richmond VA 23298, USA.
Biomedicines. 2023 May 12;11(5):1431. doi: 10.3390/biomedicines11051431.
3-O-sulfogalactosylceramide, or sulfatide, is a prominent myelin glycosphingolipid reduced in the normal appearing white matter (NAWM) in Multiple Sclerosis (MS), indicating that sulfatide reduction precedes demyelination. Using a mouse model that is constitutively depleted of sulfatide, we previously demonstrated that sulfatide is essential during development for the establishment and maintenance of myelin and axonal integrity and for the stable tethering of certain myelin proteins in the sheath. Here, using an adult-onset depletion model of sulfatide, we employ a combination of ultrastructural, immunohistochemical and biochemical approaches to analyze the consequence of sulfatide depletion from the adult CNS. Our findings show a progressive loss of axonal protein domain organization, which is accompanied by axonal degeneration, with myelin sparing. Similar to our previous work, we also observe differential myelin protein anchoring stabilities that are both sulfatide dependent and independent. Most notably, stable anchoring of neurofascin155, a myelin paranodal protein that binds the axonal paranodal complex of contactin/Caspr1, requires sulfatide. Together, our findings show that adult-onset sulfatide depletion, independent of demyelination, is sufficient to trigger progressive axonal degeneration. Although the pathologic mechanism is unknown, we propose that sulfatide is required for maintaining myelin organization and subsequent myelin-axon interactions and disruptions in these interactions results in compromised axon structure and function.
3-O-硫酸半乳糖神经酰胺,即硫苷脂,是一种显著的髓鞘糖鞘脂,在多发性硬化症(MS)患者外观正常的白质(NAWM)中含量降低,这表明硫苷脂的减少先于脱髓鞘。利用一种硫苷脂组成性缺失的小鼠模型,我们之前证明硫苷脂在发育过程中对于髓鞘和轴突完整性的建立与维持以及某些髓鞘蛋白在髓鞘中的稳定锚定至关重要。在此,我们使用硫苷脂成年发病期缺失模型,采用超微结构、免疫组织化学和生化方法相结合的方式,来分析成年中枢神经系统中硫苷脂缺失的后果。我们的研究结果显示轴突蛋白结构域组织逐渐丧失,同时伴有轴突变性,而髓鞘保留。与我们之前的研究相似,我们还观察到髓鞘蛋白锚定稳定性存在差异,这既依赖于硫苷脂,也有不依赖于硫苷脂的情况。最值得注意的是,神经束蛋白155(一种与接触蛋白/Caspr1的轴突旁节复合物结合的髓鞘旁节蛋白)的稳定锚定需要硫苷脂。总之,我们的研究结果表明成年发病期硫苷脂缺失,独立于脱髓鞘,足以引发进行性轴突变性。尽管病理机制尚不清楚,但我们提出硫苷脂对于维持髓鞘组织以及随后的髓鞘 - 轴突相互作用是必需的,而这些相互作用的破坏会导致轴突结构和功能受损。